NFKB1 and Alzheimer disease: Resveratrol, another potent polyphenol, modulates both MAPK and NF‐κB signaling in AD models, where it attenuates microglial activation, reduces pro‐inflammatory cytokine release, and protects against amyloid‐beta (Aβ)‐induced neurotoxicity (Capiralla et al. 2012).